- Home
- TRDA vs CAL Comparison
TRDA vs CAL Comparison
Compare TRDA & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- CAL
- Stock Information
- Founded
- TRDA 2016
- CAL 1878
- Country
- TRDA United States
- CAL United States
- Employees
- TRDA N/A
- CAL N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- CAL Shoe Manufacturing
- Sector
- TRDA Health Care
- CAL Consumer Discretionary
- Exchange
- TRDA Nasdaq
- CAL Nasdaq
- Market Cap
- TRDA 350.5M
- CAL 382.4M
- IPO Year
- TRDA 2021
- CAL N/A
- Fundamental
- Price
- TRDA $9.92
- CAL $10.62
- Analyst Decision
- TRDA Strong Buy
- CAL Hold
- Analyst Count
- TRDA 2
- CAL 1
- Target Price
- TRDA $24.50
- CAL $14.00
- AVG Volume (30 Days)
- TRDA 293.9K
- CAL 1.4M
- Earning Date
- TRDA 11-06-2025
- CAL 12-09-2025
- Dividend Yield
- TRDA N/A
- CAL 2.65%
- EPS Growth
- TRDA N/A
- CAL N/A
- EPS
- TRDA N/A
- CAL 1.76
- Revenue
- TRDA $61,520,000.00
- CAL $2,652,908,000.00
- Revenue This Year
- TRDA N/A
- CAL $1.74
- Revenue Next Year
- TRDA N/A
- CAL $5.85
- P/E Ratio
- TRDA N/A
- CAL $6.01
- Revenue Growth
- TRDA N/A
- CAL N/A
- 52 Week Low
- TRDA $4.93
- CAL $9.54
- 52 Week High
- TRDA $21.79
- CAL $33.25
- Technical
- Relative Strength Index (RSI)
- TRDA 76.59
- CAL 43.55
- Support Level
- TRDA $8.17
- CAL $9.54
- Resistance Level
- TRDA $9.12
- CAL $10.70
- Average True Range (ATR)
- TRDA 0.72
- CAL 0.59
- MACD
- TRDA 0.20
- CAL 0.04
- Stochastic Oscillator
- TRDA 87.16
- CAL 48.26
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.
About CAL Caleres Inc.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.